- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03985150
Biomechanical Analysis of Arterial Tissue From Patient Suffering From Peripheral Artery Disease in the Lower Limb
Biomechanical Characterization of Atherosclerotic Arterial Tissue of the Femoralis Superficialis
Study Overview
Status
Conditions
Detailed Description
Peripheral artery disease (PAD) is a severe cause of morbidity in patients. Common treatment approaches are too often still unsatisfactory. Angioplasty is commonly followed by restenosis, caused by overloading of the arterial tissue. This study is aimed at improving this treatment approach through the in silico simulation of arterial remodeling after balloon expansion. Such simulations require the input of a patient-specific geometry and the mechanical properties of (diseased) arterial tissue.
Patients scheduled for an above knee lower limb amputation due to critical ischemia will be recruited in this study. After the surgery, the femoralis superficialis will be collected, as well as the CT or MR angiogram obtained before the surgery. The arterial tissue will be mechanically tested to obtain material properties and the medical image will be used to determine the arterial geometry. A correlation study will be carried out to explore the possibility of including a predictive simulation of the restenosis outcome of balloon angioplasty in the clinical practice.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Leuven, Belgium, 3000
- Uz Leuven Campus Gasthuisberg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients suffering from critical ischemia in the lower limb and undergoing above-knee amputation
Exclusion Criteria:
- The presence of any feature that will prevent tissue collection after the amputation
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Biaxial stress-stretch curves of diseased superficial femoral arterial tissue from planar biaxial tension tests.
Time Frame: up to 3 years
|
Planar biaxial tension tests will be performed on the collected tissue.
The results of these tests, in the form of stress-stretch curves, will be fitted to existing or to be developed constitutive models describing the mechanical behavior of arterial tissue.
|
up to 3 years
|
|
Axial force and diameter curves in function of pressure from extension-inflation tests on diseased superficial femoral arterial tissue.
Time Frame: up to 3 years
|
Extension-inflation tests will be performed on the collected tissue.
The results of these tests, in the form of axial force and diameter curves, will be fitted to existing or to be developed constitutive models describing the mechanical behavior of arterial tissue.
|
up to 3 years
|
|
Reaction force curves in function of indentation depth from indentation tests on diseased superficial femoral arterial tissue.
Time Frame: up to 3 years
|
Indentation tests will be performed on the collected tissue.
The results of these tests, in the form of reaction force versus indentation depth curves, will be fitted to existing or to be developed constitutive models describing the mechanical behavior of arterial tissue.
|
up to 3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Microstructural composition of diseased superficial femoral arterial tissue from histological analyses
Time Frame: up to 3 years
|
Histological images will be analyzed to obtain the microstructural organization and composition of the collected tissue samples.
|
up to 3 years
|
|
Microstructural composition of diseased superficial femoral arterial tissue from microCT analyses
Time Frame: up to 3 years
|
MicroCT images will be analyzed to obtain the microstructural organization and composition of the collected tissue samples.
|
up to 3 years
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- S62776
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.